Blair Keagy, MD, CEO, is pleased to announce the launch of MPAnalytics, Inc. - a medical consultant group dedicated to helping businesses evaluate the commercial potential of new medical products and technologies.
CHAPEL HILL, N.C. (Business Wire EON) November 17, 2008 --
Blair Keagy, MD, CEO, is pleased to announce the launch of MPAnalytics,
Inc. - a medical consultant group dedicated to helping businesses
evaluate the commercial potential of new medical products and
technologies.
MPAnalytics provides market analysis and recommendations for new medical
devices and technology based on five key parameters: scientific merit,
reimbursement potential, competition and clinical potential, practical
market potential and clinical trial analysis. The founders of
MPAnalytics have extensive clinical experience as well as knowledge of
clinical trial design, reimbursement issues and practical markets for
new medical devices and technologies.
Dr. Blair Keagy, former Chief of Vascular Surgery at the University of
North Carolina, has authored numerous articles as well as a textbook on
healthcare economics and is considered an expert on medical
reimbursement.
“I credit my colleagues at the UNC School of
Medicine and the Kenan-Flaghler Launching the Venture Program with
helping to get this business off the ground,”
states Dr. Keagy. “Now, we have clients
enthusiastically soliciting our help in assessing the business potential
of their new medical devices or ideas before investing significant
monies in development or clinical trial.”
Ted Zoller, Executive Director, UNC Center for Entrepreneurial Studies
describes MPAnalytics as “an excellent example
of the type of entrepreneurial venture that we hope will emerge from our
program. Blair and his team have great medical expertise. MPA’s
assessment of commercial potential and their depth of market analysis
are far better than the typical medical advisory board can provide.”
The MPAnalytics team combines their competence in medical research and
the life sciences marketplace with the business savvy necessary to
create a medical consultant group that provides great value to medical
device companies and investor groups.
For more information about MPAnalytics,Inc. please contact contact Blair
Keagy at bkeagy@mpanalytics.com
, call 919.873.4047, or visit www.MPAnalytics.com.
Keyword Tags:
clinical trial, clinical trial specialist, consultant, medical, market
analysis, medical advisory board, medical consultant, medical device
consultant, medical device consultants, medical device quality
consultants, medical devices consultant, mpanalytics, new medical devices
Trackback URL: http://www.prweb.com/pingpr.php/RW1wdC1TdW1tLUhhbGYtRmFsdS1UaGlyLVNpbmctWmVybw==
|
